Futura Medical plc announced the appointment of Ken James, the former head of consumer healthcare R&D at GlaxoSmithKline plc (GSK), as a Non-Executive Director, with effect from 31 March 2016. Mr. James has more than 40 years' experience of healthcare R&D, having joined one of GSK's predecessor businesses, Beecham Products, in 1973. Mr. James recently retired from GSK.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.08 GBX | -1.87% | -1.42% | +49.31% |
04-10 | Futura Medical hails results as erectile dysfunction drug drives sales | AN |
04-10 | Transcript : Futura Medical plc, 2023 Earnings Call, Apr 10, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.31% | 147M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.69% | 21.83B | |
-10.23% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- FUM Stock
- News Futura Medical plc
- Futura Medical plc Appoints Ken James as Non-Executive Director, Effective from 31 March 2016